Schrödinger

Primary contact
Cambridge, Portland, San Diego (USA); Mannheim, München (Germany); Bangalore (India); Tokyo (Japan); Cambridge (UK); Shanghai (China)

Founded in 1990, Schrödinger, LLC is an American software company that develops chemical simulation software for use in pharmaceutical, biotechnology, and materials science research. The company provides products ranging from general molecular modeling programs to a full suite of chemical simulation and drug design software, including ligand- and structure-based methods. It also provides products in various research areas, such as small molecule modeling and simulations, macromolecular modeling and simulations, lead discovery, lead optimization, and visualization and automation. Schrödinger's software helps scientists to accelerate their research and development activities, as well as to make novel discoveries. Schrödinger establishes deep partnerships and collaborations with companies in such fields as biotechnology, pharmaceuticals, chemicals, and electronics, and helped found the biotech company Nimbus Therapeutics. Through significant long-term investments in basic research, Schrödinger has made scientific breakthroughs across many areas of drug discovery and materials science. The company has 400 commercial customers, including all top 30 pharma companies, and more than 1400 academic and government customers in 70 countries.
Primary contact
Cambridge, Portland, San Diego (USA); Mannheim, München (Germany); Bangalore (India); Tokyo (Japan); Cambridge (UK); Shanghai (China)

Funding 💰

Select investors Bill Gates, Cascade Investment
Last update: May 8, 2018